Main Article Content
Community pharmacist, Community pharmacy, Migraine, Pseudo-customer, Pregnant woman
Background: To the best of our knowledge few published studies have been conducted to evaluate customer’s care services in community pharmacies in the United Arab Emirates (UAE) using the pseudo-customer model. This further indicates that there is a paucity of information available about the current care services provided by the community pharmacists particularly for pregnant women with migraine. Objective: The main objective was to evaluate, the effectiveness of the pseudo-customer method on the care services (counseling, advice, and management) provided by the community pharmacists for migraine during pregnancy. Methods: This was a cross-sectional study conducted in community pharmacies with a cluster sampling of pharmacists. A sample of 200 community pharmacists was recruited from three emirates in the United Arab Emirates. Pregnant woman-related migraine management was assessed using the pseudo-customer model. The used script is not of a real patient but a fake/scripted used to describe the study. Results: No association was found between the gender and nationality of community pharmacists and the ability to be proactive (P =0.5, 0.568) and between the utilization of source of information and gender (P =0.31). The ability to prescribe by community pharmacists without probing or only after a probe was independent of job title (P =0.310); gender (P =0.44) and nationality (P =0.128). The community pharmacists who have offered written information have had significantly higher odds to dispense medication compared to those who have not (OR =45.547, 95% CI: 2.653 - 782.088, P =0.008). Furthermore, the pharmacists who have been reported to ask for precipitating factors of migraine had significantly higher odds to dispense medication compared to those who have not (OR =11.955, 95% CI: 1.083-131.948, P =0.043). The main outcome was the responses of the community pharmacists to the pseudocustomer visit (pregnant woman with migraine). Conclusions: The community pharmacist’s care services (counseling, advice, and management) offered to the pseudo-customer visits was effective for dealing with migraine during pregnancy.
2. Allais G, Rolando S, De Lorenzo C, et al. Migraine and pregnancy: an internet survey. Neurol Sci. 2013;34(Suppl 1):S93-99.https://doi.org/10.1007/s10072-013-1394-9
3. Kvisvik EV, Stovner LJ, Helde G, et al. Headache and migraine during pregnancy and puerperium: the MIGRA-study. J Headache Pain. 2011;12(4):443-451. https://doi.org/10.1007/s10194-011-0329-1
4. Saylor D, Steiner TJ. The global burden of headache. Semin Neurol. 2018;38(2):182-190. https://doi.org/10.1055/s-0038-1646946 5. Chen WT, Chou KH, Lee PL, et al. Comparison of gray matter volume between migraine and “strict-criteria” tension-typeheadache. J Headache Pain. 2018;19(1):1. https://doi.org/10.1186/s10194-018-0834-6
6. Anarte E, Carvalho GF, Schwarz A, et al. Can physical testing be used to distinguish between migraine and cervicogenic headache sufferers? A protocol for a systematic review. BMJ open. 2019;9(11):e031587. https://doi.org/10.1136/bmjopen-2019-031587
7. Gfrerer L, Austen Jr WG. Patient Evaluation and Diagnosis. Surgical Treatment of Chronic Headaches and Migraines. 2020;27. 8. Lapucci C, Saitta L, Bommarito G, et al. How much do periventricular lesions assist in distinguishing migraine with aura from CIS? Neurology. 2019;92(15):1739-1744. https://doi.org/10.1212/WNL.0000000000007266
9. Brune K, Patrignani P. New insights into the use of currently available non-steroidal anti-inflammatory drugs. J Pain Res. 2015;8:105-108. https://doi.org/10.2147/JPR.S75160
10. Fanelli A, Ghisi D, Aprile PL, et al. Cardiovascular and cerebrovascular risk with nonsteroidal anti-inflammatory drugs and cyclooxygenase 2 inhibitors: latest evidence and clinical implications. Ther Adv Drug Saf. 2017;8(6):173-182. https://doi.org/10.1177/2042098617690485
11. Åström K, Carlsson J, Bates I, et al. Desire for information about drugs A multi‐method study in general medical inpatients.Pharm World Sci. 2000;22(4):159-164. https://doi.org/10.1023/a:1008783115420
12. Alhomoud FK, Kunbus A, Ameer A, et al. Quality Assessment of community pharmacy services provided in the United Arab Emirates: patient experience and satisfaction. J Appl Pharm Sci. 2016;6(3):17-23.
13. Saramunee K, Krska J, Mackridge A, et al. How to enhance public health service utilization in community pharmacy? general public and health providers’ perspectives. Res Social Adm Pharm. 2014;10(2):272-284. https://doi.org/10.1016/j.sapharm.2012.05.006
14. Puspitasari HP, Aslani P, Krass I. A review of counseling practices on prescription medicines in community pharmacies. ResSocial Adm Pharm. 2009;5(3):197-210. https://doi.org/10.1016/j.sapharm.2008.08.006
15. Blom L, Krass I. Introduction: the role of pharmacy in patient education and counseling. Patient Educ Couns. 2011;83(3):285-287. https://doi.org/10.1016/j.pec.2011.05.021
16. Mendys P, Zullig LL, Burkholder R, et al. Medication adherence: process for implementation. Patient Prefer Adherence.2014;8:1025. https://doi.org/10.2147/PPA.S65041
17. Van de Steeg-van CH, Wensing M, De Smet PA. Implementation of patient education at first and second dispensing of statinsin Du tch community pharmacies: the sequel of a cluster randomized trial. BMC Health Serv Res. 2011;11(1):1.
18. Koster ES, van Meeteren MM, van Dijk M, et al. Patient–provider interaction during medication encounters: A study in outpatientpharmacies in the Netherlands. Patient Educ Couns. 2015;98(7):843-848. https://doi.org/10.1016/j.pec.2015.03.007
19. Alaqeel S, Abanmy N. Counselling practices in community pharmacies in Riyadh, Saudi Arabia: a cross-sectional study. BMC Health Serv Res. 2015;15(1):1-10. https://doi.org/10.1186/s12913-015-1220-6
20. Netere AK, Erku DA, Sendekie AK, et al. Assessment of community pharmacy professionals’ knowledge and counseling skills achievement towards headache management: a cross-sectional and simulated-client based mixed study. J Headache Pain.2018;19(1):1-9. https://doi.org/10.1186/s10194-018-0930-7
21. Alfadl AA, Alrasheedy AA, Alhassun MS. Evaluation of medication counseling practice at community pharmacies in Qassim region, Saudi Arabia. Saudi Pharm J. 2018;26(2):258-262. https://doi.org/10.1016/j.jsps.2017.12.002
22. Hasan S, Al Oum L, Hassan NA. A simulated patient study to evaluate community pharmacist assessment, management and advice giving to patients with asthma. J Pharm Policy Pract. 2021;14(1):1-0. https://doi.org/10.1186/s40545-020-00294-4
23. Alfadl AA, Alrasheedy AA, Alhassun MS. Evaluation of medication counseling practice at community pharmacies in Qassim region, Saudi Arabia. Saudi Pharm J. 2018;26(2):258-262. https://doi.org/10.1016/j.jsps.2017.12.002
24. Mináriková D, Fazekaš T, Minárik P, et al. Assessment of patient counselling on the common cold treatment at Slovak community pharmacies using mystery shopping. Saudi Pharm J. 2019;27(4):574-583. https://doi.org/10.1016/j.jsps.2019.02.005
25. Layqah LA, Alakeel YS, Shamou JZ. The practice of counseling in Pharmacy: patients’ perspectives. Int J Hosp Pharm.2018;3(17):10-5958. https://doi.org/10.15406/japlr.2018.07.00269
26. Seubert LJ, Whitelaw K, Boeni F, et al. Barriers and facilitators for information exchange during over-the-counter consultations in community pharmacy: A focus group study. Pharmacy. 2017;5(4):65. https://doi.org/10.3390/pharmacy5040065
27. Boardman HF, Heeley G. The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitors. Int J Clin Pharm. 2015;37(5):709-716. https://doi.org/10.1007/s11096-015-0150-z
28. Rayes IK, Hassali MA, Abduelkarem AR. Perception of community pharmacists toward their current professional role in the healthcare system of Dubai, United Arab Emirates. Saudi Pharm J. 2015;23(3):235-240. https://doi.org/10.1016/j. jsps.2014.11.016
29. Alhomoud FK, Kunbus A, Ameer A, et al. Quality Assessment of community pharmacy services provided in the United Arab Emirates: patient experience and satisfaction. J Appl Pharm Sci. 2016;6(3):17-23.
30. Van Dijk M, Blom L, Koopman L, et al. Patient–provider communication about medication use at the community pharmacy counter. Int J Pharm Pract. 2016;24(1):13-21. https://doi.org/10.1111/ijpp.12198